| Jillian Moore, DO | |
|
4400 Broadway Blvd Ste 302, Kansas City, MO 64111-3342 | |
| (816) 931-9344 | |
| (816) 931-4168 |
| Full Name | Jillian Moore |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 4400 Broadway Blvd Ste 302, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144684085 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2020022059 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ferns, Matile, Perryman And Moore, M.d.'s, P.a. | 9830137041 | 6 |
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
CTBC Bank (USA) and its parent company CTBC Financial Holdings have donated $200,000 as a global partner to the Huntsman Cancer Foundation, which kicks off its new annual Championship for Cancer Research fundraiser.
Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.
As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure.
Catalent Pharma Solutions, the leading provider of advanced oral drug delivery technologies to the pharmaceutical industry, has entered into a strategic alliance with Endotis Pharma for the development of oral formulations of synthetic oligosaccharides.
› Verified 3 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
CTBC Bank (USA) and its parent company CTBC Financial Holdings have donated $200,000 as a global partner to the Huntsman Cancer Foundation, which kicks off its new annual Championship for Cancer Research fundraiser.
Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.
As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure.
Catalent Pharma Solutions, the leading provider of advanced oral drug delivery technologies to the pharmaceutical industry, has entered into a strategic alliance with Endotis Pharma for the development of oral formulations of synthetic oligosaccharides.
› Verified 3 days ago
| Entity Name | Ferns, Matile, Perryman & Moore, M.d.'s, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063457141 PECOS PAC ID: 9830137041 Enrollment ID: O20050419000801 |
News Archive
CTBC Bank (USA) and its parent company CTBC Financial Holdings have donated $200,000 as a global partner to the Huntsman Cancer Foundation, which kicks off its new annual Championship for Cancer Research fundraiser.
Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.
As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure.
Catalent Pharma Solutions, the leading provider of advanced oral drug delivery technologies to the pharmaceutical industry, has entered into a strategic alliance with Endotis Pharma for the development of oral formulations of synthetic oligosaccharides.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jillian Moore, DO 4400 Broadway Blvd Ste 302, Kansas City, MO 64111-3342 Ph: (816) 931-9344 | Jillian Moore, DO 4400 Broadway Blvd Ste 302, Kansas City, MO 64111-3342 Ph: (816) 931-9344 |
News Archive
CTBC Bank (USA) and its parent company CTBC Financial Holdings have donated $200,000 as a global partner to the Huntsman Cancer Foundation, which kicks off its new annual Championship for Cancer Research fundraiser.
Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.
As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure.
Catalent Pharma Solutions, the leading provider of advanced oral drug delivery technologies to the pharmaceutical industry, has entered into a strategic alliance with Endotis Pharma for the development of oral formulations of synthetic oligosaccharides.
› Verified 3 days ago
Susan Marie Mou, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2101 Charlotte St, Kansas City, MO 64108 Phone: 816-404-7820 Fax: 816-404-8159 | |
Dr. Kristopher Shawn Lybarger, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd Bldg 2, Ste 546, Kansas City, MO 64132 Phone: 816-926-0777 Fax: 816-926-0707 | |
Ronald Edward Brunnabend Ii, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd Ste 598, Kansas City, MO 64132 Phone: 816-444-6888 | |
Douglas R Perryman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4400 Broadway Ste 302, Kansas City, MO 64111 Phone: 816-931-9344 Fax: 816-931-4168 | |
Anupama Kotha, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-3584 Fax: 816-932-5873 | |
Zachary James Alholm, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-0880 | |
Gerald Lee Miller Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6400 Prospect, #598, Kansas City, MO 64132 Phone: 816-444-6888 Fax: 816-444-1375 |